raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:411515

Angelman syndrome due to imprinting defect in 15q11-q13

Type
Etiological subtype
Group
Subtype of disorder
Inheritance
Not applicable
Age of onset
Infancy
Status
active

This disease is described under Angelman syndrome

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAngelman syndrome due to imprinting defect in 15q11-q13
frSyndrome d'Angelman dû à un défaut d'empreinte de la région 15q11-q13
deAngelman-Syndrom durch Imprinting-Defekt in 15q11-q13
esSíndrome de Angelman por un defecto de impronta en 15q11-q13
itSindrome di Angelman da difetto dell'imprinting in regione 15q11-q13
nlSyndroom van Angelman door imprintingsdefect in 15q11-q13
ptSíndrome Angelman por anomalia do imprinting no locus 15q11-q13
plZespół Angelmana spowodowany defektem imprintingu 15q11-q13
csAngelmanův syndrom způsobený poruchou imprintingu 15q11-q13
ukСиндром Ангельмана, зумовлений дефектом імпринтингу в 15q11-q13
zh15q11-q13印迹缺陷导致的天使综合征
tr15q11-q13'teki imprinting defektine bağlı Angelman sendromu
2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10Q93.5NTBTattributedvalidated
ICD-11LD90.0NTBTattributedvalidated
MONDO0018462Evalidated
UMLSC5681834Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

  • ORPHA:72Angelman syndrome
    rare developmental anomalies during embryogenesis; rare genetic diseases; rare neurological diseases

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ATP10ARole in the phenotype ofAssessedHGNC:13542ENSG0000020619060585515q12ATPase phospholipid transporting 10A (putative)11326269[PMID]_17347796[PMID]
SNRPNRole in the phenotype ofAssessedHGNC:11164ENSG0000012873918227915q11.2small nuclear ribonucleoprotein polypeptide N17347796[PMID]_22670133[PMID]_24876791[PMID]_25212744[PMID]_20301323[PMID]
UBE3ARole in the phenotype ofAssessedHGNC:12496ENSG0000011406260162315q11.2ubiquitin protein ligase E3A17347796[PMID]_22670133[PMID]_24876791[PMID]_25212744[PMID]_20301323[PMID]
5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

27 annotations · validated 2020-11-03
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0001999Abnormal facial shape
HP:0031936Delayed ability to walk
HP:0002353EEG abnormality
HP:0008872Feeding difficulties in infancy
HP:0008947Floppy infant
HP:0040082Happy demeanor
HP:0005599Hypopigmentation of hair
HP:0001010Hypopigmentation of the skin
HP:0000748Inappropriate laughter
HP:0007730Iris hypopigmentation
HP:0001513Obesity
HP:0002591Polyphagia
HP:0001250Seizure
Occasional (29-5%)
HP:0001344Absent speech
HP:0001251Ataxia
HP:0000708Atypical behavior
HP:0410263Brain imaging abnormality
HP:0002136Broad-based gait
HP:0004485Cessation of head growth
HP:0002307Drooling
HP:0000752Hyperactivity
HP:0000710Hyperorality
HP:0000303Mandibular prognathia
HP:0002465Poor speech
HP:0000736Short attention span
HP:0006979Sleep-wake cycle disturbance
HP:0000154Wide mouth

Annotation source: 20301323[PMID]_26040994[PMID]_28211971[PMID]

7

Sources for this card